Search For "antibody"
Updated : 4 weeks ago IST
An artificial blood-brain barrier model that has been constructed by researchers at Uppsala University is quick and accurate, and it may be used to assess how well antibody-based treatments can reach the brain. The new model may lessen the requirement for animal testing, which is now the mos
Updated : 1 month ago IST
New Delhi [India], February 23 (ANI/PNN): KnowDis and IIT Delhi's Yardi School of Artificial Intelligence are collaborating to develop cutting-edge Artificial Intelligence models that can discover potential antibodies for treating various kinds of diseases. The collaboration involves two ren
Updated : 1 month, 2 weeks ago IST
There is currently no medication available to treat non-alcoholic liver disease, which affects many type 2 diabetes patients and can develop into more serious liver ailments. A therapeutic option for the treatment of fatty liver has been identified in a study led by Karolinska Institute rese
There is presently no medication available to treat non-alcoholic fatty liver disease, which affects many patients with type 2 diabetes and can lead to other serious liver illnesses. A therapeutic candidate for the treatment of fatty liver has been identified in a study headed by Karolinska
Updated : 1 month, 3 weeks ago IST
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.
A method for finding high-affinity antibody therapeutics that is based on artificial intelligence (AI) has been created by researchers at the University of California San Diego School of Medicine.
Updated : 2 months, 3 weeks ago IST
The most recent study clarifies how Pfizer and Moderna mRNA boosters influence the persistence of our Covid-19 antibodies. According to the researchers, a booster produced more durable antibodies in all individuals, including those who had recovered from a Covid-19 infection.
Updated : 2 months, 4 weeks ago IST
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l
Updated : 3 months ago IST
According to a study, patients with thyroid eye disease treated with the minimally invasive insulin-like growth factor I blocking antibody teprotumumab saw improvements in their symptoms, appearance, and quality of life.
Updated : 3 months, 1 week ago IST
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
Updated : 3 months, 2 weeks ago IST
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
The treatment, which is referred to as a "bispecific antibody," binds to both T cells and multiple myeloma cells and instructs the T cells, which are white blood cells that can be used to fight off diseases